Top

Published in:

01-10-2012 | Substance Use and Related Disorders (JR McKay, Section Editor)

Management of Pain With Comorbid Substance Abuse

Authors: Daniel Krashin, Natalia Murinova, Jane Ballantyne

Published in: Current Psychiatry Reports | Issue 5/2012

Abstract

Substance use disorders are a large public health problem in the United States. Over the past decade, there has been a trend of increased prescription drug misuse, morbidity, and mortality related to prescription opioids. For providers who treat pain, this has led to clinical dilemmas as the newly appreciated risks must be balanced with the benefits of treatment, particularly in patients with known substance use disorders. Acute, chronic, and palliative each present distinct issues in pain treatment. A best practices model of pain treatment, including risk stratification and integrative treatment, may provide the best prospect for safe and effective treatment.

Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–55.PubMedCrossRef

Administration SAMHS. Results from the 2010 National Survey on drug use and health: summary of national findings. MD: Rockville; 2011.

Morasco BJ, Gritzner S, Lewis L, et al. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152:488–97.PubMedCrossRef

Catalano RF, White HR, Fleming CB, Haggerty KP. Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 2011;36:79–86.PubMedCrossRef

Cicero TJ, Surratt HL, Kurtz S, et al. Patterns of prescription opioid abuse and comorbidity in an aging treatment population. J Subst Abus Treat. 2012;42:87–94.CrossRef

Ahlbeck K. Opioids. A two-faced Janus. Curr Med Res Opin. 2011;27:439–48.PubMedCrossRef

Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87–95.PubMedCrossRef

• Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev. 2011;30:264–70. An excellent overview of the analgesic misuse problem in the USA. PubMedCrossRef

Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–75.PubMedCrossRef

10.

Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981–5.PubMedCrossRef

11.

Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325–8.

12.

Green TC, Black R, Grimes Serrano JM, et al. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS One. 2011;6:e27244.PubMedCrossRef

13.

Kalant H. What neurobiology cannot tell us about addiction. Addiction. 2010;105:780–9.PubMedCrossRef

14.

O'Brien C. Addiction and dependence in DSM-V. Addiction. 2011;106:866–7.PubMedCrossRef

15.

Heit HA. Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. J Pain Palliat Care Pharmacother. 2003;17:15–29.PubMed

16.

Jamison RN, Ross EL, Michna E, et al. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150:390–400.PubMedCrossRef

17.

•• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Off J Am Pain Soc: J Pain. 2009;10:113–30. These guidelines contain a wealth of specific advice for managing common dilemmas in pain treatment.

18.

Younger JW, Chu LF, D'Arcy NT, et al. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152:1803–10.PubMedCrossRef

19.

• Skurtveit S, Furu K, Borchgrevink P, et al. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain. 2011;152:1555–61. This study demonstrates low risk of addiction in low dose acute opioid treatment. PubMedCrossRef

20.

Gentilello LM, Rivara FP, Donovan DM, et al. Alcohol interventions in a trauma center as a means of reducing the risk of injury recurrence. Ann Surg. 1999;230:473–80. discussion 480–473.PubMedCrossRef

21.

Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212–27.PubMedCrossRef

22.

Neighbor ML, Dance TR, Hawk M, Kohn MA. Heightened pain perception in illicit substance-using patients in the ED: implications for management. Am J Emerg Med. 2011;29:50–6.PubMedCrossRef

23.

Barry DT, Goulet JL, Kerns RK, et al. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011;152:1133–8.PubMedCrossRef

24.

•• Edlund MJ, Martin BC, Fan MY, et al. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112:90–8. This study demonstrates the phenomena of “adverse selection” and high-risk opioid prescribing. PubMedCrossRef

25.

Morasco BJ, Corson K, Turk DC, Dobscha SK. Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. J Pain. 2011;12:352–9.PubMed

26.

Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J Gen Intern Med. 2011;26:965–71.PubMedCrossRef

27.

Carroll CP, Haythornthwaite J. Maladaptive opioid use behaviors and psychiatric illness: what should we do with what we know? Curr Pain Headache Rep. 2011;15:91–3.PubMedCrossRef

28.

Goebel JR, Compton P, Zubkoff L, et al. Prescription sharing, alcohol use, and street drug use to manage pain among veterans. J Pain Symptom Manage. 2011;41:848–58.PubMedCrossRef

29.

Chan BK, Tam LK, Wat CY, et al. Opioids in chronic non-cancer pain. Expert Opin Pharmacother. 2011;12:705–20.PubMedCrossRef

30.

Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011;124:955–60.PubMedCrossRef

31.

Morasco BJ, Duckart JP, Carr TP, et al. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010;151:625–32.PubMedCrossRef

32.

Silverberg MJ, Ray GT, Saunders K, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28:39–46.PubMedCrossRef

33.

Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain. 2010;150:332–9.PubMedCrossRef

34.

Clark MR, Treisman GJ. Optimizing treatment with opioids and beyond. In: Clark MR, Treisman GJ, editors. Chronic Pain and Addiction. 2011. pp. 92–112.

35.

Hwang SW, Wilkins E, Chambers C, et al. Chronic pain among homeless persons: characteristics, treatment, and barriers to management. BMC Fam Pract. 2011;12:73.PubMedCrossRef

36.

Heiwe S, Lonnquist I, Kallmen H. Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication. Eur J Pain. 2011;15:966–70.PubMedCrossRef

37.

Ilgen MA, Haas E, Czyz E, et al. Treating chronic pain in veterans presenting to an addictions treatment program. Cogn Behav Pract. 2011;18:149–60.CrossRef

38.

Manchikanti L, Singh V, Caraway DL, Benyamin RM. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse. Pain Physician. 2011;14:E103–17.PubMed

39.

• Simone CB, Vapiwala N, Hampshire MK, Metz JM. Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain. 2012;28:157–62. The concerns of typical cancer pain patients are studied, including both undertreatment and addiction. PubMedCrossRef

40.

Dev R, Parsons HA, Palla S, et al. Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer. 2011;117:4551–6.PubMedCrossRef

41.

Kircher S, Zacny J, Apfelbaum SM, et al. Understanding and treating opioid addiction in a patient with cancer pain. J Pain. 2011;12:1025–31.PubMedCrossRef

42.

Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107–12.PubMedCrossRef

43.

Becker WC, Starrels JL, Heo M, et al. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011;9:219–25.PubMedCrossRef

44.

Vijayaraghavan M, Penko J, Guzman D, et al. Primary care providers' judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. J Gen Intern Med. 2011;26:412–8.PubMedCrossRef

45.

McGeary DD, McGeary CA, Gatchel RJ. A comprehensive review of telehealth for pain management: where we are and the way ahead. Pain Pract. 2012.

46.

Meltzer EC, Rybin D, Saitz R, et al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011;152:397–402.PubMedCrossRef

47.

Moore T, Jones T, Browder J, et al. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009;10:1426–33.PubMedCrossRef

48.

Bohn TM, Levy LB, Celin S, et al. Screening for abuse risk in pain patients. In: Clark MR and Treisman GJ, editors. Chronic pain and addiction. 2011. pp. 113–24.

49.

Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRef

50.

Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14:123–43.PubMed

51.

Gupta A, Patton C, Diskina D, Cheatle M. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Pain Physician. 2011;14:383–9.PubMed

52.

•• Starrels JL, Becker WC, Alford DP, et al. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–20. This study demonstrates the benefits and limitations of these treatment practices. PubMed

53.

Jones JD, Sullivan MA, Manubay J, et al. The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. Neuropsychopharmacology. 2011;36:411–22.PubMedCrossRef

Title: Management of Pain With Comorbid Substance Abuse
Authors: Daniel Krashin
Natalia Murinova
Jane Ballantyne
Publication date: 01-10-2012
Publisher: Current Science Inc.
Published in: Current Psychiatry Reports / Issue 5/2012
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-012-0298-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Management of Pain With Comorbid Substance Abuse

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2012

Personalized Treatment of Alcohol Dependence

Is Chronic Insomnia a Precursor to Major Depression? Epidemiological and Biological Findings

Treatment of Tobacco Dependence in People With Mental Health and Addictive Disorders

Neuroimaging of Attention-Deficit/Hyperactivity Disorder: Current Neuroscience-Informed Perspectives for Clinicians

Obstructive Sleep Apnea and Severe Mental Illness: Evolution and Consequences

Emerging Association Between Addictive Gaming and Attention-Deficit/Hyperactivity Disorder